2021. 03. Launched QBON product

2020. 05. Launched QBONPLUG product

2019. 12. Acquired European CE certificate

2019. 02. Acquired EN ISO 13485:2016 certificate

2018. 10. Launched FRABONE-W product

2018. 09. Launched FRABONE-C product

2018. 01. Obtained GMP approval for relocated facilities

2017. 11. Head Office and GMP facilities relocated

2017. 06. Launched FRABONE®-H product

2016. 08. Acquired NET(New Excellent Technology) Certificate
No. 124 from Ministry of Health and welfare
(Bone cell adhesion fluid type biodegradation control bone
graft material manufacturing technology)

2015. 11. Acquired EN ISO 13485 certificate

2015. 04. Launched FRABONE product

2015. 02. Acquired NET(New Excellent Technology) Certificate
No. 99 from Ministry of Health and welfare
(Multi-pass extrusion synthetic bone graft manufacturing technology)

2014. 04. Acquired KFDA approval for FRABONE

2014. 04. Established R&D center

2014. 03. Acquired certificate of quality management standards for medical device manufacturers(KGMP)

2013. Conducted joint research projects with soonchumhyang University

~ Developed double layered electrospun hydrogels for bone hemostatic applications

2012. Developed prototypes for high performance orthopedic implants

2011. 02. Joined Soonchumhyang University's Business Incubator Tenants(BIT)

2010. 11. Established Inobone Co. Ltd